Adam Bierman

Get ready to dive into the world of cannabis entrepreneurship as Bungalow Media + Entertainment along with writer and producer Zach Goldbaum undertake a three-part series about Adam Bierman, the mastermind behind MedMen Enterprises Inc, the first American cannabis unicorn. The series is based on...

In the bustling streets of San Francisco, a partnership that seeks to change the face of the cannabis industry is born. Adam Bierman has teamed up with Bombatta, an up-and-coming Bay Area cannabis street brand led by Brianna McGee, a nurse with a mission to promote the compassionate use of cannabis...

In the latest episode of The Hoban Minute, a popular cannabis-focused podcast hosted by industry experts Bob Hoban and Xavier Jaillet, listeners are treated to an engaging conversation with Adam Bierman, former CEO of MedMen (OTC: MMNFF) and prominent cannabis advocate. MedMen, a trailblazing...

Adam Bierman and Andrew Modlin founded MedMen (OTC: MMNFF) in 2010. Since then the company, which started with a single store in California,  skyrocketed off the technical graphs, becoming the first mainstream cannabis company in the world to hit every screen in America. The kickstart of...

Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: MMNFF) is opening a new store in Boston's Fenway Park - its first in Massacusssets. Located on 120 Brookline Avenue, the 4,725 square-foot shop will kick off cannabis sales on Wednesday, Dec. 22. "As we continue to execute...

A company run by the ousted co-founders of cannabis giant MedMen (OTC: MMNFF), Adam Bierman and Andrew Modlin, are suing Coastal Holding Co., a company that holds several cannabis licenses in multiple California cities, over planning to sell the company for $56.2 million, reported Law360. The...

A week filled of cannabis news ended with the departure of MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF)’s CEO Adam Bierman, who left the company after a massive restructuring and considerable reduction in its workforce. Bierman also agreed to return his Class A super voting shares to...

MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) announced Friday that CEO Adam Bierman is stepping down from the role effective Feb. 1. Ryan Lissack, the cannabis company's chief operating officer and chief technology officer, has been named interim CEO.  Bierman To Surrender Class A...

By Natan Ponieman and Javier Hasse. Medmen Enterprises Inc. (OTC: MMNFF) has the premier brand and pre-eminent footprint in the U.S. cannabis industry, CEO Adam Bierman said in an interview with Benzinga. The CEO acknowledges that MedMen was forced to lay off over 40% of its workforce during...

By Natan Ponieman and Javier Hasse. In late November, the cannabis dispensary chain Medmen Enterprises Inc (OTC: MMNFF) was sailing in rough seas after reporting losses of $79 million over a one-year period ended June 29.  CEO Adam Bierman and his team announced a new, 90-day...

MedMen Enterprises Inc (OTC: MMNFF) (CSE: MMEN) announced Tuesday it has terminated the deal to acquire multi-state cannabis operator Pharmacann. The company is also terminating its chief financial officer, Michael Kramer. What Happened In a conversation with Benzinga, MedMen CEO Adam Bierman...

U.S. cannabis retailer MedMen Enterprises Inc (CSE: MMEN) (OTC: MMNFF) announced Monday the start of its delivery service across California, allowing consumers to experience the comfort of home delivery. The company will concentrate on California, where it has 17 retail locations, aiming for its...

Cannabis retailer MedMen Enterprises (OTCQX: MMNFF)(CSE:MMEN) announced Wednesday it gained an additional equity commitment from Gotham Green Partners in the amount of $30 million. The additional equity commitment was created with Wicklow Capital’s assistance, making Gotham Green Partners...

Medmen Enterprises Inc (OTC: MMNFF) is a grower and retailer of marijuana that operates in California, Nevada and New York. On Tuesday Medmen CEO Adam Bierman was a guest on CNBC's "Mad Money" to discuss the company's "blockbuster" $682 million acquisition of PharmaCann...